| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.095 | 0.02 |